UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of GLP-1 agonist-based weight loss therapies. The WeDosify software promises to ...
However, individuals using a hybrid closed-loop system had a higher rate of ketoacidosis (1.74 events per 100 patient-years) than those using open-loop therapy (0.96 per 100 patient-years). The rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results